XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCKHOLDERS’ EQUITY
9 Months Ended
Nov. 30, 2018
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10 – STOCKHOLDERS’ EQUITY

Stock Repurchase

 

On May 7, 2018, we announced that our Board of Directors authorized a share repurchase program under which we could repurchase up to $30.0 million of our outstanding common stock over the next 12 months. On July 16, 2018, our Board of Directors increased it to $39.0 million.

 

During the quarter ended November 30, 2018, we repurchased approximately 0.5 million shares of our common stock at an average share price of $19.85 for a total cost of $10.4 million. As of November 30, 2018, the entire $39.0 million authorized by our Board of Directors has been utilized.

 

On December 10, 2018, we announced that our Board of Directors authorized a new share repurchase program under which we may repurchase up to $20.0 million of our outstanding common stock over the next 12 months. Under the stock repurchase program, we may repurchase shares in the open market.

 

Employee Stock Purchase Plan

 

On June 7, 2018, our Board of Directors adopted the CalAmp Corp. 2018 Employee Stock Purchase Plan (the “ESPP”), which was approved by our stockholders on July 25, 2018. The ESPP provides for the issuance of 1,750,000 shares of our common stock. The first enrollment under the ESPP Plan will commence in February 2019.

Equity Awards

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

November 30,

 

 

November 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of revenues

 

$

251

 

 

$

198

 

 

$

640

 

 

$

477

 

Research and development

 

 

538

 

 

 

427

 

 

 

1,323

 

 

 

1,045

 

Selling and marketing

 

 

808

 

 

 

677

 

 

 

2,059

 

 

 

1,610

 

General and administrative

 

 

1,344

 

 

 

1,318

 

 

 

4,066

 

 

 

3,532

 

 

 

$

2,941

 

 

$

2,620

 

 

$

8,088

 

 

$

6,664

 

 

Changes in our outstanding stock options during the nine months ended November 30, 2018 were as follows (options in thousands):

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise Price

 

 

Weighted average remaining contractual life (years)

 

 

Aggregate intrinsic value

 

Outstanding at February 28, 2018

 

 

980

 

 

$

11.29

 

 

 

5.9

 

 

 

 

 

Granted

 

 

140

 

 

 

23.08

 

 

 

 

 

 

 

 

 

Exercised

 

 

(66

)

 

 

1.87

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at November 30, 2018

 

 

1,054

 

 

$

13.44

 

 

 

6.1

 

 

$

5,501

 

Exercisable at November 30, 2018

 

 

672

 

 

$

9.98

 

 

 

4.5

 

 

$

5,223

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the nine months ended November 30, 2018 were as follows (restricted shares, PSUs and RSUs in thousands):

 

 

 

Number of Restricted

Shares, PSUs

and RSUs

 

 

Weighted

Average Grant

Date Fair Value

 

 

Shares Retained to Cover Statutory Minimum Withholding Taxes

 

Outstanding at February 28, 2018

 

 

1,434

 

 

$

17.72

 

 

 

 

 

Granted

 

 

714

 

 

 

22.81

 

 

 

 

 

Vested

 

 

(461

)

 

 

17.28

 

 

 

156

 

Forfeited

 

 

(161

)

 

 

19.45

 

 

 

 

 

Outstanding at November 30, 2018

 

 

1,526

 

 

$

20.05

 

 

 

 

 

 

As of November 30, 2018, there was $29.2 million of total unrecognized stock-based compensation cost related to outstanding nonvested equity awards that is expected to be recognized as an expense over a weighted-average remaining vesting period of 3.4 years.